Garner is an excellent choice for MD.
He is the best going around in Oz.
Kazia stock didn’t do well but that happens in biotech land when the drug doesn’t work!! That’s the game we are playing.
He is very good with investors and regulatory pathways. I have heard institutional investors rate him.
Charmaine as Executive Chairman. Things are going to get spicy.
Ann: Chief Executive Officer and Managing Director Appointment, page-7
-
- There are more pages in this discussion • 101 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $94.66M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 9.8¢ | $58.09K | 574.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 38503 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 194063 | 5 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |